MedPath

A pharmacokinetic study to assess the effect of two different formulations of Testosterone Metered Dose (MD) Lotion on the pharmacokinetics of testosterone in hypogonadism

Phase 1
Completed
Conditions
Hypogonadism
Metabolic and Endocrine - Diabetes
Registration Number
ACTRN12605000528651
Lead Sponsor
Acrux DDS Pty Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
12
Inclusion Criteria

Healthy volunteers

Exclusion Criteria

No exclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath